The Brain Health Study: A Pragmatic, Patient-Centered Trial
Completed · Not applicable
Conditions studied: Dementia, Alzheimer Disease
In brief
The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
Key facts
- Study ID
- NCT05356702
- Run by
- Kaiser Permanente
- People needed
- 3417
- Starts
- 2022-06-29
- Expected to finish
- 2026-03-03
- Last updated by the study team
- 2026-07-06
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia
- Active patient at participating clinic
- Adequate data to calculate eRADAR score
You may not qualify if…
- Currently receiving hospice care
Where it is running
- Kaiser Permanente Burien Medical Center — Burien, Washington, United States
- Kaiser Permanente Kent Medical Center — Kent, Washington, United States
- Kaiser Permanente Renton Medical Center — Renton, Washington, United States
- Kaiser Permanente, Capitol Hill — Seattle, Washington, United States
- Kaiser Permanente Northgate Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.